Pacific Biosciences Of California (PACB) Non Operating Income (2010 - 2026)

Pacific Biosciences Of California's Non Operating Income history runs 17 years deep, the most recent figure standing at $2.0 million for Q1 2026.

• In Q1 2026, Non Operating Income fell 53.28% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $12.5 million (down 41.51% YoY), while the FY2025 annual figure was $14.8 million, down 37.95% from the prior year.
• Non Operating Income was $2.0 million for Q1 2026 at Pacific Biosciences Of California, down from $2.8 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $8.9 million in Q2 2023 to a low of -$279000.0 in Q1 2022.
• Historically, Non Operating Income has averaged $4.8 million across 5 years, with a median of $4.7 million in 2025.
• Biggest YoY gain for Non Operating Income was 634700.0% in 2022; the steepest drop was 535.94% in 2022.
• A 5-year view of Non Operating Income shows it stood at $6.3 million in 2022, then soared by 32.06% to $8.4 million in 2023, then slumped by 51.51% to $4.1 million in 2024, then sank by 31.91% to $2.8 million in 2025, then slipped by 27.53% to $2.0 million in 2026.
• The last three Non Operating Income figures came in at $2.0 million (Q1 2026), $2.8 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.